Most patients with heart failure likely to benefit from a pacemaker including the capacity for cardiac resynchronization therapy (CRT) do not receive such an implantable device, reports a national study in the December 2009 issue of the American Heart Journal. Less than half who qualify for the device therapy may actually get it, the large-scale study led by University of South Florida cardiologist Anne Curtis, MD, found.
- Most eligible patients miss out on cardiac resynchronization therapy for heart failureFri, 11 Dec 2009, 18:32:24 EST
- New therapy found to prevent heart failureTue, 23 Jun 2009, 14:22:08 EDT
- Researchers pinpoint patients who receive greatest benefit from heart failure treatmentTue, 1 Mar 2011, 13:02:19 EST
- Patients with heart block see strong benefit from cardiac resynchronization therapyTue, 6 Nov 2012, 21:03:03 EST
- Stuy in NEJM: New therapy prevents heart failureTue, 1 Sep 2009, 12:43:39 EDT